290 related articles for article (PubMed ID: 31748429)
1. Association between circulating zinc-α2-glycoprotein levels and the different phenotypes of polycystic ovary syndrome.
Tang C; Li X; Tang S; Wang Y; Tan X
Endocr J; 2020 Mar; 67(3):249-255. PubMed ID: 31748429
[TBL] [Abstract][Full Text] [Related]
2. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
[TBL] [Abstract][Full Text] [Related]
3. Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome.
Lai Y; Chen J; Li L; Yin J; He J; Yang M; Jia Y; Liu D; Liu H; Liao Y; Yang G
Sci Rep; 2016 May; 6():25934. PubMed ID: 27180914
[TBL] [Abstract][Full Text] [Related]
4. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
5. Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment.
Zheng S; Liu E; Zhang Y; Long T; Liu X; Gong Y; Mai T; Shen H; Chen H; Lin R; Zheng Y; Xie Y; Wang F
Endocr J; 2019 Jun; 66(6):555-562. PubMed ID: 30918134
[TBL] [Abstract][Full Text] [Related]
6. The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios.
Qu C; Zhou X; Yang G; Li L; Liu H; Liang Z
Cytokine; 2016 Mar; 79():96-102. PubMed ID: 26797477
[TBL] [Abstract][Full Text] [Related]
7. Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome.
Abruzzese GA; Gamez J; Belli SH; Levalle OA; Mormandi E; Otero P; Graffigna MN; Cerrone GE; Motta AB
Gynecol Endocrinol; 2020 Dec; 36(12):1057-1061. PubMed ID: 32496833
[TBL] [Abstract][Full Text] [Related]
8. Free androgen index and Irisin in polycystic ovary syndrome.
Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
[TBL] [Abstract][Full Text] [Related]
9. Several Circulating Biomarkers for PCOS Diagnosis.
Luo P; Zhang C; He Y; Yang G; Liu H; Li L
Exp Clin Endocrinol Diabetes; 2021 Oct; 129(10):705-712. PubMed ID: 31683329
[TBL] [Abstract][Full Text] [Related]
10. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
11. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
12. Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.
Yang M; Liu R; Li S; Luo Y; Zhang Y; Zhang L; Liu D; Wang Y; Xiong Z; Boden G; Chen S; Li L; Yang G
Diabetes Care; 2013 May; 36(5):1074-82. PubMed ID: 23275352
[TBL] [Abstract][Full Text] [Related]
13. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
[TBL] [Abstract][Full Text] [Related]
15. Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction.
Li J; Wu Q; Wu XK; Zhou ZM; Fu P; Chen XH; Yan Y; Wang X; Yang ZW; Li WL; Stener-Victorin E; Legro RS; Ng EH; Zhang H; Mol BWJ; Wang CC;
Hum Reprod; 2018 Apr; 33(4):617-625. PubMed ID: 29471520
[TBL] [Abstract][Full Text] [Related]
16. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
Hosseinpanah F; Barzin M; Keihani S; Ramezani Tehrani F; Azizi F
Clin Endocrinol (Oxf); 2014 Jul; 81(1):93-9. PubMed ID: 24428207
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
18. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.
Ożga K; Krzyczkowska-Sendrakowska M; Hubalewska-Dydejczyk A; Gilis-Januszewska A; Ratajczak M; Ratajczak M; Chaykivska Z; Jach R
Endokrynol Pol; 2019; 70(4):330-335. PubMed ID: 30938834
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.
Tosi F; Bonora E; Moghetti P
Hum Reprod; 2017 Dec; 32(12):2515-2521. PubMed ID: 29040529
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.
Krentowska A; Kowalska I
Diabetes Metab Res Rev; 2022 Jan; 38(1):e3464. PubMed ID: 33988288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
